Mardepodect

View Clinical trials for Mardepodect Get Mardepodect Patent Info for Free

PF-02545920 is a PDE10 Inhibitor that is in development at Pfizer for Huntington’s Disease and as an adjunctive treatment for Schizophrenia

Inn NameMardepodect
Usan NameMardepodect
Lab CodesPF-02545920, PF-0254920, PF-2545920, MP-10
Chemical Name2-({4-[1-methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline
Chemical StructureMardepodect.png
Molecular FormulaC25H20N4O
SmilesCn1cc(c(n1)c2ccc(cc2)OCc3ccc4ccccc4n3)c5ccncc5
Cas Registry Number898562-94-2
Orphan Drug StatusYes
Orphan IndicationHuntington's disease
New Molecular EntityYes
OriginatorPfizer
Mechanism Of ActionPhosphodiesterase-10 (PDE-10) inhibitor
Who Atc CodesN05A (Antipsychotics)
N07X (Other Nervous System Drugs)
Ephmra CodesN5A (Antipsychotics)
N7X (All other CNS drugs)
IndicationSchizophrenia, Huntington's Disease

Free counters!